Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference1%
- Check25 days agoChange DetectedAdded a new version label (v3.1.0) and removed several safety-focused topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs), indicating a shift in page scope away from those subjects.SummaryDifference0.2%
- Check39 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check54 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as the removal of outdated location references. Notably, the total number of study locations has decreased from 96 to 93.SummaryDifference8%
- Check68 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.